Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

J Riesenfeld

Showing results (21-30 of 57) with videos related to

Pageof 6
Sort By:
The Biochemical Journal|September 1, 1980
Interaction of lipoprotein lipase with native and modified heparin-like polysaccharidesG Bengtsson, T Olivecrona, M Höök, et al.
Genome Biology|July 1, 2010
Genomics through the lens of next-generation sequencingJohn A Capra, Lucia Carbone, Samantha J Riesenfeld, et al.
Immunological Reviews|October 9, 2018
Type 2 innate lymphoid cells in the induction and resolution of tissue inflammationAntonia Wallrapp, Samantha J Riesenfeld, Patrick R Burkett, et al.
The Journal of Biological Chemistry|October 25, 1984
Extension and structural variability of the antithrombin-binding sequence in heparinU Lindahl, L Thunberg, G Bäckström, et al.
The Biochemical Journal|September 1, 1988
Biosynthesis of heparin. Modulation of polysaccharide chain length in a cell-free systemK Lidholt, J Riesenfeld, K G Jacobsson, et al.
Analytical Biochemistry|November 1, 1983
Assay of N-acetylheparosan deacetylase with a capsular polysaccharide from Escherichia coli K5 as substrateJ L Navia, J Riesenfeld, W F Vann, et al.
The Journal of Biological Chemistry|October 25, 1988
Biosynthesis of heparin. O-sulfation of the antithrombin-binding regionM Kusche, G Bäckström, J Riesenfeld, et al.
The Gerontologist|January 1, 1972
Perceptions of public service needs: the urban elderly and the public agencyM J Riesenfeld, R J Newcomber, P V Berlant, et al.
Thrombosis and Haemostasis|September 24, 1999
Platelet compatibility of an artificial surface modified with functionally active heparinT E Mollnes, V Videm, D Christiansen, et al.
Pediatric Hematology and Oncology|March 24, 1998
Doxorubicin reversibly decreases the antithrombogenicity of heparin immobilized on central venous cathetersF Lundberg, D Falkenback, A N Békássy, et al.
Pageof 6

Showing results (21-30 of 57) with videos related to

Sort By:
Pageof 6
The Biochemical Journal|September 1, 1980
Interaction of lipoprotein lipase with native and modified heparin-like polysaccharidesG Bengtsson, T Olivecrona, M Höök, et al.
Genome Biology|July 1, 2010
Genomics through the lens of next-generation sequencingJohn A Capra, Lucia Carbone, Samantha J Riesenfeld, et al.
Immunological Reviews|October 9, 2018
Type 2 innate lymphoid cells in the induction and resolution of tissue inflammationAntonia Wallrapp, Samantha J Riesenfeld, Patrick R Burkett, et al.
The Journal of Biological Chemistry|October 25, 1984
Extension and structural variability of the antithrombin-binding sequence in heparinU Lindahl, L Thunberg, G Bäckström, et al.
The Biochemical Journal|September 1, 1988
Biosynthesis of heparin. Modulation of polysaccharide chain length in a cell-free systemK Lidholt, J Riesenfeld, K G Jacobsson, et al.
Analytical Biochemistry|November 1, 1983
Assay of N-acetylheparosan deacetylase with a capsular polysaccharide from Escherichia coli K5 as substrateJ L Navia, J Riesenfeld, W F Vann, et al.
The Journal of Biological Chemistry|October 25, 1988
Biosynthesis of heparin. O-sulfation of the antithrombin-binding regionM Kusche, G Bäckström, J Riesenfeld, et al.
The Gerontologist|January 1, 1972
Perceptions of public service needs: the urban elderly and the public agencyM J Riesenfeld, R J Newcomber, P V Berlant, et al.
Thrombosis and Haemostasis|September 24, 1999
Platelet compatibility of an artificial surface modified with functionally active heparinT E Mollnes, V Videm, D Christiansen, et al.
Pediatric Hematology and Oncology|March 24, 1998
Doxorubicin reversibly decreases the antithrombogenicity of heparin immobilized on central venous cathetersF Lundberg, D Falkenback, A N Békássy, et al.
Pageof 6